The Journal of Experimental Medicine
BioLegend: Antibody Reagents
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online January 14, 2008
doi:10.1084/jem.20071944
The Journal of Experimental Medicine, Vol. 205, No. 1, 245-256
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Aliahmad et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Aliahmad, P.
Right arrow Articles by Kaye, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aliahmad, P.
Right arrow Articles by Kaye, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Development of all CD4 T lineages requires nuclear factor TOX

Parinaz Aliahmad and Jonathan Kaye

Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

CORRESPONDENCE Jonathan Kaye:jkaye{at}scripps.edu

CD8+ cytotoxic and CD4+ helper/inducer T cells develop from common thymocyte precursors that express both CD4 and CD8 molecules. Upon T cell receptor signaling, these cells initiate a differentiation program that includes complex changes in CD4 and CD8 expression, allowing identification of transitional intermediates in this developmental pathway. Little is known about regulation of these early transitions or their specific importance to CD4 and CD8 T cell development. Here, we show a severe block at the CD4loCD8lo transitional stage of positive selection caused by loss of the nuclear HMG box protein TOX. As a result, CD4 lineage T cells, including regulatory T and CD1d-dependent natural killer T cells, fail to develop. In contrast, functional CD8+ T cells develop in TOX-deficient mice. Our data suggest that TOX-dependent transition to the CD4+CD8lo stage is required for continued development of class II major histocompatibility complex–specific T cells, regardless of ultimate lineage fate.


Abbreviations used: {alpha}GalCer, {alpha}-galactosylceramide; β2M, β2-microglobulin; DD, CD4loCD8lo double dull; DP, CD4+CD8+ double positive; ERK, extracellular signal–regulated kinase; ES, embryonic stem; ETP, early T lineage precursor; NKT cell, natural killer T; PI, propidium iodide; SP, single positive; TAP, transporter associated with antigen processing; Tg, transgenic; TOX or Tox, thymocyte selection–associated HMG box protein or gene, respectively; T reg, T regulatory.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS